Zobrazeno 1 - 10
of 46
pro vyhledávání: '"H G, Derigs"'
Publikováno v:
Mediators of Inflammation, Vol 7, Iss 3, Pp 195-199 (1998)
The stimulation of granulocyte macrophage-colony stimulating factor (GM-CSF) by interleukin-1 (IL-1) has been shown to be counteracted in different mesenchymal cell systems by cyclic adenosine monophosphate (cAMP) agonists. The aim of this study was
Externí odkaz:
https://doaj.org/article/3f9f8fd5179f49ae9a44c7318497df52
Autor:
M-O. Zahn, Josef Thaler, Christine Windemuth-Kieselbach, Gudrun Piringer, Sandro Anchisi, F. Scholten, R.D. Hofheinz, R. von Moos, B. Grünberger, Pierre Oliver Bohanes, Stefanie Pederiva, H. Kröning, H.-G. Derigs
Publikováno v:
Annals of Oncology. 32:S574-S575
Autor:
Dirk Behringer, S. Bröckling, Lothar Müller, J-C. Moulin, S-E. Al-Batran, Claudia Pauligk, Arndt Vogel, T. Fietz, Anna Saborowski, N. Moosmann, Christoph B. Westphalen, T.O. Götze, Jochem Potenberg, Manfred P. Lutz, M.K. Schuler, E. Späth-Schwalbe, J. Chater, Frank Hartmann, B. Zäpf, H.-G. Derigs
Publikováno v:
Annals of Oncology. 32:S1255
Autor:
Kathleen M Mullane, Vicki A Morrison, Luis H Camacho, Ann Arvin, Shelly A McNeil, Jessie Durrand, Bernadette Campbell, Shu-Chih Su, Ivan S F Chan, Janie Parrino, Susan S Kaplan, Zoran Popmihajlov, Paula W Annunziato, S Cerana, MO Dictar, P Bonvehi, JP Tregnaghi, L Fein, D Ashley, M Singh, T Hayes, G Playford, O Morrissey, J Thaler, T Kuehr, R Greil, M Pecherstorfer, L Duck, K Van Eygen, M Aoun, B De Prijck, FA Franke, CHE Barrios, AVA Mendes, SV Serrano, RF Garcia, F Moore, JFC Camargo, LA Pires, RS Alves, A Radinov, K Oreshkov, V Minchev, AI Hubenova, T Koynova, I Ivanov, B Rabotilova, PA Petrov, P Chilingirov, S Karanikolov, J Raynov, D Grimard, S McNeil, D Kumar, LM Larratt, K Weiss, R Delage, FJ Diaz-Mitoma, PO Cano, F Couture, P Carvajal, A Yepes, R Torres Ulloa, P Fardella, C Caglevic, C Rojas, E Orellana, P Gonzalez, A Acevedo, KM Galvez, ME Gonzalez, S Franco, JG Restrepo, CA Rojas, C Bonilla, LE Florez, AV Ospina, R Manneh, R Zorica, DV Vrdoljak, M Samarzija, L Petruzelka, J Vydra, J Mayer, D Cibula, J Prausova, G Paulson, M Ontaneda, K Palk, A Vahlberg, R Rooneem, F Galtier, D Postil, F Lucht, F Laine, O Launay, H Laurichesse, X Duval, OA Cornely, B Camerer, J Panse, M Zaiss, H-G Derigs, H Menzel, M Verbeek, V Georgoulias, D Mavroudis, A Anagnostopoulos, E Terpos, D Cortes, J Umanzor, S Bejarano, RW Galeano, RSM Wong, P Hui, P Pedrazzoli, L Ruggeri, F Aversa, A Bosi, G Gentile, A Rambaldi, A Contu, L Marei, A Abbadi, W Hayajneh, J Kattan, F Farhat, G Chahine, J Rutkauskiene, LJ Marfil Rivera, YA Lopez Chuken, H Franco Villarreal, J Lopez Hernandez, H Blacklock, RI Lopez, R Alvarez, AM Gomez, TS Quintana, MDC Moreno Larrea, SJ Zorrilla, E Alarcon, FCA Samanez, PB Caguioa, BJ Tiangco, EM Mora, RD Betancourt-Garcia, D Hallman-Navarro, LJ Feliciano-Lopez, HA Velez-Cortes, F Cabanillas, DE Ganea, TE Ciuleanu, DG Ghizdavescu, L Miron, CL Cebotaru, CI Cainap, R Anghel, MV Dvorkin, OA Gladkov, NV Fadeeva, AA Kuzmin, ON Lipatov, II Zbarskaya, FS Akhmetzyanov, IV Litvinov, BV Afanasyev, M Cherenkova, D Lioznov, IA Lisukov, YA Smirnova, S Kolomietz, H Halawani, YT Goh, L Drgona, J Chudej, M Matejkova, M Reckova, BL Rapoport, WM Szpak, DR Malan, N Jonas, CW Jung, DG Lee, SS Yoon, J Lopez Jimenez, I Duran Martinez, JF Rodriguez Moreno, C Solano Vercet, R de la Camara, M Batlle Massana, S-P Yeh, C-Y Chen, H-H Chou, C-M Tsai, C-H Chiu, N Siritanaratkul, L Norasetthada, V Sriuranpong, K Seetalarom, H Akan, F Dane, MA Ozcan, GH Ozsan, SF Kalayoglu Besisik, A Cagatay, S Yalcin, A Peniket, SR Mullan, KM Dakhil, K Sivarajan, JJ-G Suh, A Sehgal, F Marquez, EG Gomez, MR Mullane, WL Skinner, RJ Behrens, DR Trevarthe, MA Mazurczak, EA Lambiase, CA Vidal, SY Anac, GA Rodrigues, B Baltz, R Boccia, MS Wertheim, CS Holladay, D Zenk, W Fusselman, JL Wade III, AJ Jaslowsk, J Keegan, MO Robinson, RS Go, J Farnen, B Amin, D Jurgens, GF Risi, PG Beatty, T Naqvi, S Parshad, VL Hansen, M Ahmed, PD Steen, S Badarinath, A Dekker, MA Scouros, DE Young, W Graydon Harker, SD Kendall, ML Citron, S Chedid, JG Posada, MK Gupta, S Rafiyath, J Buechler-Price, S Sreenivasappa, CH Chay, JM Burke, SE Young, A Mahmood, JW Kugler, G Gerstner, J Fuloria, ND Belman, R Geller, J Nieva, BP Whittenberger, BMY Wong, TP Cescon, G Abesada-Terk, MJ Guarino, A Zweibach, EN Ibrahim, G Takahashi, MA Garrison, RB Mowat, BS Choi, IA Oliff, J Singh, KA Guter, K Ayrons, KM Rowland, SJ Noga, SB Rao, A Columbie, MT Nualart, GR Cecchi, LT Campos, M Mohebtash, MR Flores, R Rothstein-Rubin, BM O'Connor, G Soori, M Knapp, FG Miranda, BW Goodgame, M Kassem, R Belani, S Sharma, T Ortiz, HL Sonneborn, AB Markowitz, D Wilbur, E Meiri, VS Koo, HS Jhangiani, L Wong, S Sanani, SJ Lawrence, CM Jones, C Murray, C Papageorgiou, JS Gurtler, JL Ascensao, ML Venigalla, M D'Andrea, C De Las Casas, DJ Haile, FU Qazi, JL Santander, MR Thomas, VP Rao, M Craig, RJ Garg, R Robles, RM Lyons, RK Stegemoller, S Goel, S Garg, P Lowry, C Lynch, B Lash, T Repka, J Baker, BS Goueli, TC Campbell, DA Van Echo, YJ Lee, EA Reyes, FM Senecal, G Donnelly, P Byeff, R Weiss, T Reid, E Roeland, A Goel, DM Prow, DS Brandt, HG Kaplan, JE Payne, MG Boeckh, PJ Rosen, RR Mena, R Khan, RF Betts, SA Sharp, VA Morrison, D Fitz-Patrick, J Congdon, N Erickson, R Abbasi, S Henderson, A Mehdi, EJ Wos, E Rehmus, L Beltzer, RA Tamayo, T Mahmood, AC Reboli, A Moore, JM Brown, J Cruz, DP Quick, JL Potz, KW Kotz, M Hutchins, NM Chowhan, YD Devabhaktuni, P Braly, RA Berenguer, SC Shambaugh, TJ O'Rourke, WA Conkright, CF Winkler, FEK Addo, JP Duic, KP High, ME Kutner, R Collins, DR Carrizosa, DJ Perry, E Kailath, N Rosen, R Sotolongo, S Shoham, T Chen
Summary Background Patients who are immunocompromised because of malignancy have an increased risk of herpes zoster and herpes zoster-related complications. We aimed to investigate the efficacy and safety of an inactivated varicella zoster virus (VZV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9512b960de076ec44f04d635a16f9143
http://hdl.handle.net/11573/1331005
http://hdl.handle.net/11573/1331005
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Annals of Oncology. 30:v224-v225
Background The anti-angiogenic fusion protein AFL targets VEGF-A, VEGF-B and PlGF. It is approved in combination with FOLFIRI for treatment of mCRC that is resistant to or has progressed after oxaliplatin-containing therapy. Methods QoLiTrap is an on
Publikováno v:
Annals of Oncology. 30:iv118
Publikováno v:
Annals of Oncology. 29:viii192
Autor:
Robert Huddart, Johannes Classen, Roberto Salvioni, Rainer Souchon, Walter Albrecht, Xavier Garcia del Muro, Malcolm David Mason, Michael Bamberg, Johnathan Joffe, Jutta Scheiderbauer, Annette Dieing, Oscar Leiva Galvis, Niels E. Skakkebæk, Ronald de Wit, William G. Jones, Sophie D. Fosså, Kai Uwe Koehrmann, H. G. Derigs, Silke Gillessen, Martin Fenner, Sergei Tjulandin, C Clemm, Wolfgang Hoeltl, Padraig Warde, Aude Flechon, Luis Paz Ares, Pieter H.M. De Mulder, S. Kliesch, Nicola Nicolai, Thomas Powles, László Kisbenedek, Lothar Weissbach, Craig R. Nichols, Hans von der Maase, Michael Jewett, Jörg Pont, Markus A. Kuczyk, Volker Loy, Christian Wittekind, Peter Albers, Jose Ramon Germa-Lluch, Felix Sedlmayer, Giovanni Rosti, D. Ondruš, Pilar Laguna, Heinz Schmidberger, István Bodrogi, Gabriella Cohn-Cedermark, Eva Cavallin-Ståhl, Jörg Beyer, Tim Oliver, Arthur Gerl, Gedske Daugaard, Stefan Weinknecht, Tobias Pottek, Hans-Joachim Schmoll, Maike de Wit, Rolf Mueller, Maria De Santis, Michael Hartmann, Graham M. Mead, Oliver Rick, Jean Pierre Droz, Christian K. Kollmannsberger, Hans U. Schmelz, Karim Fizazi, Gosse O N Oosterhof, Lori Wood, Thomas Gauler, Aslam Sohaib, Susanne Krege, Ferran Algaba, Alan Horwich, Eva Winter, Stéphane Culine, Giorgio Pizzocaro, Olbjørn Klepp, Axel Heidenreich, Klaus Peter Dieckmann, Jörg T. Hartmann, Mark Schrader, Lajos Géczi, Carsten Bokemeyer
Publikováno v:
European Urology
European Urology, Elsevier, 2008, 53 (3), pp.497-513. ⟨10.1016/j.eururo.2007.12.025⟩
European Urology, 53, 3, pp. 497-513
European Urology, 53, 478-496
European Urology, 53, 3, pp. 478-496
European Urology, 2008, 53 (3), pp.497-513. ⟨10.1016/j.eururo.2007.12.025⟩
European Urology, 53, 497-513
European Urology, 53(3), 478-496. Elsevier
European Urology, 53(3), 497-513. Elsevier
European Urology, Elsevier, 2008, 53 (3), pp.497-513. ⟨10.1016/j.eururo.2007.12.025⟩
European Urology, 53, 3, pp. 497-513
European Urology, 53, 478-496
European Urology, 53, 3, pp. 478-496
European Urology, 2008, 53 (3), pp.497-513. ⟨10.1016/j.eururo.2007.12.025⟩
European Urology, 53, 497-513
European Urology, 53(3), 478-496. Elsevier
European Urology, 53(3), 497-513. Elsevier
Objectives: The first consensus report presented by the European Germ Cell Cancer Consensus Group (EGCCCG) in the year 2004 has found widespread approval by many colleagues throughout the world. In November 2006, the group met a second time under the
Autor:
N. Nicolai, O. Leiva, Johnathan K Joffe, O. Klepp, P. Walz, Rolf Mueller, M. de Wit, S. Clemm, S. D. Fossa, Niels E. Skakkebæk, Gedske Daugaard, Robert Huddart, S. Tjulandin, M. Kuczyk, S. Krege, M. D. Mason, G. Kaiser, X. Garcia del Muro, László Kisbenedek, Gosse O N Oosterhof, O. Rick, Wolfgang Hoeltl, S. Kliesch, H. von der Maase, M. Bamberg, A. Gerl, N. Aass, Christian Kollmannsberger, G. Pizzocaro, M. Hartmann, L. Weissbach, O. Pont, U. Studer, P. Albers, M.P. Laguna, V. Loy, R. Souchon, H.-J. Schmoll, J. P. Droz, P.H.M. de Mulder, Heinz Schmidberger, Jörg Beyer, K. Fizazi, Tobias Pottek, J. Classen, G. M. Mead, Alan Horwich, L. Paz Ares, C. Bokemeyer, W. Jones, Eva Winter, T. Oliver, H. G. Derigs, J. R. Germa-Lluch, Felix Sedlmayer, István Bodrogi, Stefan Weinknecht, M. Flasshove, A. Heidenreich, F. Algaba, R. de Wit, S. Culine, K. U. Koehrmann, C. Wittekind, J. T. Hartmann, K. P. Dieckmann, W. Siegert, G. Rosti
Publikováno v:
Annals of Oncology, 15, 9, pp. 1377-99
Annals of Oncology, 15, 1377-99
Annals of Oncology, 15, 1377-1399. Elsevier Ltd.
Schmoll, H J, Souchon, R, Krege, S, Albers, P, Beyer, J, Kollmannsberger, C, Fossa, S D, Skakkebaek, N E, de Wit, R, Fizazi, K, Droz, J P, Pizzocaro, G, Daugaard, G, de Mulder, P H, Horwich, A, Oliver, T, Huddart, R, Rosti, G, Paz Ares, L, Pont, O, Hartmann, J T, Aass, N, Algaba, F, Bamberg, M, Bodrogi, I, Bokemeyer, C, Classen, J, Clemm, S, Culine, S, de Wit, M, Derigs, H G, Dieckmann, K P, Flasshove, M, Garcia del Muro, X, Gerl, A, Germa-Lluch, J R, Hartmann, M, Heidenreich, A, Hoeltl, W, Joffe, J, Jones, W, Kaiser, G, Klepp, O, Kliesch, S, Kisbenedek, L, Koehrmann, K U, Kuczyk, M, Laguna, M P, Leiva, O, Loy, V, Mason, M D, Mead, G M, Mueller, R P, Nicolai, N, Oosterhof, G O, Pottek, T, Rick, O, Schmidberger, H, Sedlmayer, F, Siegert, W, Studer, U, Tjulandin, S, Maase, H V D, Walz, P, Weinknecht, S, Weissbach, L, Winter, E & Wittekind, C 2004, ' European consensus on diagnosis and treatment of germ cell cancer : A report of The European Germ Cell Cancer Consensus Group (EGCCCG) ', European Urology, vol. 15, pp. 1377-1399 .
Annals of Oncology, 15, 1377-99
Annals of Oncology, 15, 1377-1399. Elsevier Ltd.
Schmoll, H J, Souchon, R, Krege, S, Albers, P, Beyer, J, Kollmannsberger, C, Fossa, S D, Skakkebaek, N E, de Wit, R, Fizazi, K, Droz, J P, Pizzocaro, G, Daugaard, G, de Mulder, P H, Horwich, A, Oliver, T, Huddart, R, Rosti, G, Paz Ares, L, Pont, O, Hartmann, J T, Aass, N, Algaba, F, Bamberg, M, Bodrogi, I, Bokemeyer, C, Classen, J, Clemm, S, Culine, S, de Wit, M, Derigs, H G, Dieckmann, K P, Flasshove, M, Garcia del Muro, X, Gerl, A, Germa-Lluch, J R, Hartmann, M, Heidenreich, A, Hoeltl, W, Joffe, J, Jones, W, Kaiser, G, Klepp, O, Kliesch, S, Kisbenedek, L, Koehrmann, K U, Kuczyk, M, Laguna, M P, Leiva, O, Loy, V, Mason, M D, Mead, G M, Mueller, R P, Nicolai, N, Oosterhof, G O, Pottek, T, Rick, O, Schmidberger, H, Sedlmayer, F, Siegert, W, Studer, U, Tjulandin, S, Maase, H V D, Walz, P, Weinknecht, S, Weissbach, L, Winter, E & Wittekind, C 2004, ' European consensus on diagnosis and treatment of germ cell cancer : A report of The European Germ Cell Cancer Consensus Group (EGCCCG) ', European Urology, vol. 15, pp. 1377-1399 .
Germ cell tumour is the most frequent malignant tumour type in young men with a 100% rise in the incidence every 20 years. Despite this, the high sensitivity of germ cell tumours to platinum-based chemotherapy, together with radiation and surgical me